Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Hatch

Showing results (261-270 of 298) with videos related to

Pageof 30
Sort By:
American Journal of Obstetrics and Gynecology|March 1, 1985
Nutritional status of patients with untreated cervical cancer. I. Biochemical and immunologic assessmentJ W Orr, K Wilson, C Bodiford, et al.
American Journal of Obstetrics and Gynecology|March 1, 1985
Nutritional status of patients with untreated cervical cancer. II. Vitamin assessmentJ W Orr, K Wilson, C Bodiford, et al.
American Journal of Obstetrics and Gynecology|December 1, 1985
Corpus and cervix cancer: a nutritional comparisonJ W Orr, K Wilson, C Bodiford, et al.
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|July 1, 1994
Succinylcholine warningR Bingham, E Battersby, A Black, et al.
JAMA|February 1, 1992
Folate deficiency and cervical dysplasiaC E Butterworth, K D Hatch, M Macaluso, et al.
Gynecologic Oncology|November 1, 1991
Rationale for using pathologic tumor dimensions and nodal status to subclassify surgically treated stage IB cervical cancer patientsR D Alvarez, M E Potter, S J Soong, et al.
Virology|August 29, 1998
Inhibition of influenza virus hemagglutinin-mediated membrane fusion by a compound related to podocarpic acidK A Staschke, S D Hatch, J C Tang, et al.
Gynecologic Oncology|November 25, 1998
In vitro phase II comparison of the cytotoxicity of a novel platinum analog, nedaplatin (254-S), with that of cisplatin and carboplatin against fresh, human cervical cancersB J Monk, D S Alberts, R A Burger, et al.
American Journal of Obstetrics and Gynecology|April 1, 1982
Urinary diversion in patients undergoing pelvic exenterationJ W Orr, H M Shingleton, K D Hatch, et al.
Journal of Medicinal Chemistry|January 5, 1996
Potent human immunodeficiency virus type 1 protease inhibitors that utilize noncoded D-amino acids as P2/P3 ligandsL N Jungheim, T A Shepherd, A J Baxter, et al.
Pageof 30

Showing results (261-270 of 298) with videos related to

Sort By:
Pageof 30
American Journal of Obstetrics and Gynecology|March 1, 1985
Nutritional status of patients with untreated cervical cancer. I. Biochemical and immunologic assessmentJ W Orr, K Wilson, C Bodiford, et al.
American Journal of Obstetrics and Gynecology|March 1, 1985
Nutritional status of patients with untreated cervical cancer. II. Vitamin assessmentJ W Orr, K Wilson, C Bodiford, et al.
American Journal of Obstetrics and Gynecology|December 1, 1985
Corpus and cervix cancer: a nutritional comparisonJ W Orr, K Wilson, C Bodiford, et al.
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|July 1, 1994
Succinylcholine warningR Bingham, E Battersby, A Black, et al.
JAMA|February 1, 1992
Folate deficiency and cervical dysplasiaC E Butterworth, K D Hatch, M Macaluso, et al.
Gynecologic Oncology|November 1, 1991
Rationale for using pathologic tumor dimensions and nodal status to subclassify surgically treated stage IB cervical cancer patientsR D Alvarez, M E Potter, S J Soong, et al.
Virology|August 29, 1998
Inhibition of influenza virus hemagglutinin-mediated membrane fusion by a compound related to podocarpic acidK A Staschke, S D Hatch, J C Tang, et al.
Gynecologic Oncology|November 25, 1998
In vitro phase II comparison of the cytotoxicity of a novel platinum analog, nedaplatin (254-S), with that of cisplatin and carboplatin against fresh, human cervical cancersB J Monk, D S Alberts, R A Burger, et al.
American Journal of Obstetrics and Gynecology|April 1, 1982
Urinary diversion in patients undergoing pelvic exenterationJ W Orr, H M Shingleton, K D Hatch, et al.
Journal of Medicinal Chemistry|January 5, 1996
Potent human immunodeficiency virus type 1 protease inhibitors that utilize noncoded D-amino acids as P2/P3 ligandsL N Jungheim, T A Shepherd, A J Baxter, et al.
Pageof 30